e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
The burden of respiratory infections in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
T. Sergey, G. Nina (Krasnoyarsk, Russian Federation)
Source:
Annual Congress 2013 –The burden of respiratory infections in children
Session:
The burden of respiratory infections in children
Session type:
Thematic Poster Session
Number:
1210
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sergey, G. Nina (Krasnoyarsk, Russian Federation). Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?. Eur Respir J 2013; 42: Suppl. 57, 1210
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Monitoring of
Mycoplasma pneumoniae
and
Chlamydia pneumoniae
in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001
Severe
Chlamydia pneumoniae
community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Clinical aspects of chlamydia pneumoniae pneumonia in adults
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Mycoplasma pneumoniae
infections in a paediatric setting; changes in epidemiology and clinical presentation
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Community-acquired pneumonia in younger patients is an entity on its own
Source: Eur Respir J 2012; 39: 1156-1161
Year: 2012
Penicillin-resistant
streptococcus pneumoniae
is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
Community-acquired pneumonia in outpatients: aetiology and outcomes},
Source: Eur Respir J 2012; 40: 931-938
Year: 2012
Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Community-acquired pneumonia
Source: Respipedia Article
Year: 2017
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Clinical peculiarities of mycoplasma infection in children with community pneumonia
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Macrolide-resistant
Mycoplasma pneumoniae
in adolescents with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept